https://www.selleckchem.com/pr....oducts/ndi-091143.ht
8 vs 29.4%; HR 1.25, 95% CI 1.14-1.36). In conclusion, VTE might increase the risk of critical lower limb events (PTA and above-knee amputation), systemic thromboembolism, and mortality in the AF population. However, current data cannot confirm a causal relationship between VTE and clinical outcomes in this population.Aim We aimed to explore ceruloplasmin (CP) expression in clear cell renal cell carcinoma (ccRCC). Materials methods CP was analyzed in biofluid samples of 63 ccRCC patients, divided into three grading groups, and